Back to search

East Tennessee State University

HIV Integrase Inhibitor Pharmacogenetics and Clinical Outcomes: An Exploratory Association Study

Abstract

dc:description.abstract

As HIV is now primarily a chronic condition, treatment is given life-long with changes as necessitated by alterations in tolerability and efficacy. Thus, personalized medicine may be useful in the prevention of unnecessary drug exposure and avoidable side effects. Three of the four currently available HIV integrase strand transfer inhibitors (INSTIs), raltegravir, elvitegravir, and dolutegravir, are widely utilized antiretrovirals in the USA and exhibit variations in outcomes among subjects. To interrogate differences among subjects receiving these drugs, we investigated the association of several single nucleotide polymorphisms (SNPs) with drug exposure, clinical outcomes, and subject-reported adverse events. HIV+ adults (≥18 years old) receiving an INSTI regimen were recruited (n=88). Subject genotypes were evaluated using an iPLEX PGx Panel. Genetic variations within our population, underwent multiple regression with covariates [age, sex, BMI, regimen duration, and baseline variables (as required) along with specific regimen in the comprehensive group] to detect significant (p=0.028) between abnormal dream occurrence and specific INSTI regimen with the raltegravir grouping presenting a higher frequency. This exploratory study also discovered several SNP-outcome associations when using INSTIs. Although these SNPs were found to have a role in predicting segments of adverse effect profiles, the clinical significance of these findings remains to be determined. Larger studies will be needed to confirm these exploratory findings with functional studies to understand pathogeneses. In conclusion, the associations found in this study strengthen the need for further assessment, within the HIV+ population, of factors contributing to unfavorable subject outcomes.

Degree

thesis:*
Name thesis:degree_name
PhD (Doctor of Philosophy)
Level thesis:degree_level
Dissertation - unrestricted
Discipline thesis:degree_discipline
Biomedical Sciences
Grantor dc:publisher
East Tennessee State University
Year dc:date.issued
2018

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Murrell, Derek E

Subjects

dc:subject × 9

Rights

dc:rights
Statement dc:rights
  • Copyright by the authors.
Language dc:language
eng

Identifiers

dc:identifier.*
Repository record dc:identifier
https://dc.etsu.edu/etd/3465

Chain of custody

source
Harvested from
East Tennessee State University
Base URL
dc.etsu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Murrell, Derek E. HIV Integrase Inhibitor Pharmacogenetics and Clinical Outcomes: An Exploratory Association Study. Dissertation - unrestricted thesis, East Tennessee State University, 2018. https://dc.etsu.edu/etd/3465